✓ Translated by DotMD AI Clinical Council Source: Climacteric : the journal of the International Menopause Society • Randomized Controlled Trial
Verify Primary Source: NIH PubMed PMID #16857659 ↗

Randomized Controlled Trial: Adverse mood effects during postmenopausal hormone treatment in relation to personality traits (N = 106)

Original Paper Title: “Adverse mood effects during postmenopausal hormone treatment in relation to personality traits”

Elena Rostova (AI Quant) Rigor Score
82 / 100
Sample Size (Participants)
N = 106
Evidence Classification
Randomized Controlled Trial
Sarah Jenkins, RN (AI Plain-English Editor) • Key Takeaways
  • Women with a history of PMS and women with a high anxiety-related personality might respond with adverse mood effects to a combination of estrogen and sequential progestin and therefore a thorough evaluation should be made, at the consultation for hormone therapy, of mood benefits or disadvantages before initiation of treatment and there.
  • Study Design & Sample: Randomized Controlled Trial published in Climacteric : the journal of the International Menopause Society (N = 106 human participants).
  • Biostatistical Rigor Score: 82/100 audited by Elena Rostova (AI Biostatistician & openFDA Quant).

What the Study Found (In Plain English)

Published in Climacteric : the journal of the International Menopause Society (2006), this randomized controlled trial evaluating 106 human participants investigated: When postmenopausal women are treated with sequential hormone therapy (HT), cyclical mood swings similar to symptoms seen in the premenstrual dysphoric disorder (PMDD) are described. Key clinical takeaway: Women with a history of PMS and women with a high anxiety-related personality might respond with adverse mood effects to a combination of estrogen and sequential progestin and therefore a thorough evaluation should be made, at the consultation for hormone therapy, of mood benefits or disadvantages...

Dr. Lin (AI Evidence Lead): Statistical Endpoints & Numbers

Primary Endpoint & Quantitative Summary (Climacteric : the journal of the International Menopause Society, 2006-08-15; N = 106; Rigor 82/100): Women with a history of PMS and women with a high anxiety-related personality might respond with adverse mood effects to a combination of estrogen and sequential progestin and therefore a thorough evaluation should be made, at the consultation for hormone therapy, of mood benefits or disadvantages before initiation of treatment and there.

Study Limitations & Caveats Before You Act

Clinical trials evaluate specific inclusion/exclusion cohorts under protocol-controlled conditions (Randomized Controlled Trial). Individual response, hepatic/renal clearance, CYP450 drug interactions, and baseline comorbidities vary; verify applicability with a board-certified physician before modifying any prescription or supplement regimen.

Related DotMD Clinical Hubs & Price Ledgers

Rx: estradiol-vaginal-cream → Rx: estradiol → Rx: 3-6oz-biest-2-5-estrogen-cream-estriol-estradiol-estrogen-cream → Rx: biest-5-0-estrogen-cream-3-6oz-estriol-estradiol → Condition: menopause → Condition: premenstrual-syndrome →
Transparent AI Research Council • Grounded on NIH / FDA / PubMed Data

Ask our AI Specialists anything about PMID 16857659: Randomized Controlled Trial: Adverse mood effects during postmenopausal hormone treatment in relation to personality traits (N = 106)

3 of 3 Free Questions Remaining